This research develops water-free electrolyte systems for electrochemical reactions and energy technologies. By replacing water with more stable solvents, the work enables improved batteries, renewable energy storage, and more efficient chemical manufacturing. Applications include long-range electric vehicles, planetary exploration systems, and lower-cost pharmaceutical production using recyclable chemical reagents.

This research develops methods to insert radioactive carbon isotopes into drug molecules, allowing scientists to track how medicines move, transform, and are eliminated in the body. By using catalysts to precisely label drugs, researchers can better understand drug behaviour and accelerate the development of safer, more effective medicines.

This research addresses antibiotic resistance by developing new compounds effective against Pseudomonas aeruginosa. Using engineered Streptomyces albus, it produces uridyl peptide antibiotics with a triple-target mechanism that reduces resistance risk. The work focuses on purification and chemical optimization to create more effective, clinically viable antibiotics for future infections.